Investor Alert: Kaplan Fox Announces Investigation Of American Renal Associates Holdings

Tuesday, March 12, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, March 11, 2019 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com)

is investigating claims on behalf of investors of American Renal Associates Holdings, Inc. ("American Renal" or the "Company") (NYSE: ARA), a company that through its subsidiaries owns and operates kidney dialysis centers.  Investors that purchased American
Renal securities may be affected.

On March 8, 2019, American Renal announced that it was delaying the filing of its annual report on Form 10-K for the fiscal year ended December 31, 2018, as well as the issuance of its earnings release for the fourth quarter and full year 2018.

American Renal also reported that its Audit Committee review is continuing and, with the assistance of its advisors, that its Audit Committee is examining reserve computations and other accounting practices that could have an impact on accounts receivable and revenue for fiscal year 2018, as well as previously reported fiscal years from 2014 through 2017.

Following this news, American Renal's shares fell $2.05 per share, about 16.4%, to close at $10.46 per share on March 8, 2019.

If you are an investor and would like to discuss our investigation, please contact us by emailing pmayer@kaplanfox.com or by calling 800-290-1952.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Kaplan Fox & Kilsheimer LLP, with offices in New York, San Francisco, Los Angeles, Chicago and New Jersey, has many years of experience in prosecuting investor class actions. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.  If you have any questions about this your rights, or your interests, please contact:

Jeffrey P. CampisiKAPLAN FOX & KILSHEIMER LLP850 Third Avenue, 14th FloorNew York, New York 10022(800) 290-1952(212) 687-1980Fax: (212) 687-7714E-mail: jcampisi@kaplanfox.com

Laurence D. KingKAPLAN FOX & KILSHEIMER LLP350 Sansome Street, Suite 400 San Francisco, California  94104(415) 772-4700Fax:  (415) 772-4707E-mail: lking@kaplanfox.com

 

Cision View original content:http://www.prnewswire.com/news-releases/investor-alert-kaplan-fox-announces-investigation-of-american-renal-associates-holdings-300810446.html

SOURCE Kaplan Fox & Kilsheimer LLP



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store